CD8A and lung cancer: Research has demonstrated that ZNF683+CD8+T cell totality is important for anti-tumor immunity, with high levels of this ZNF683 gene marker detected in peripheral blood samples from patients with renal cell carcinoma, melanoma, and lung cancer (32).